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clinical snippets
AD in the  
United States
Because most data concerning 
the prevalence of atopic 
dermatitis (AD) in industrialized 
countries derive from European 
population studies, Shaw and 
colleagues determined the 
prevalence of AD as well as 
geographic and demographic 
associations in the United 
States using data from the 
National Survey of Children’s 
Health, which surveyed more 
than 100,000 families from all 
50 states. The prevalence of 
AD in children in the United 
States was found to be 10.7%, 
in agreement with previous 
estimates. Considerable 
variability was observed among 
states and districts. Urban 
living, black race, and higher 
education were significantly 
associated with higher AD 
prevalence. See page 67
Tanning Sensor
Investigations of the 
environmental link between 
the transcription factor aryl 
hydrocarbon receptor (AhR) 
and melanogenesis by Jux and 
colleagues revealed that mice 
deficient in AhR exhibited 
decreased tanning and 
tyrosinase activity in response 
to UVB irradiation. This AhR-
dependent response is specific 
to melanocytes and involves 
a UVB-mediated increase 
in melanocyte density and 
changes in gene expression. 
Importantly, these results 
suggest that modulation of AhR 
signaling in melanocytes may 
be useful to induce or prevent 
skin pigmentation in healthy 
skin or perhaps to induce 
pigmentation in patients with 
vitiligo. See page 203
Epithelial Interferon
In agreement with the similarities between 
type I IFNs and the newly identified type 
III IFN (IFN-λ) specific for epithelial cells, 
Zahn and colleagues provide evidence 
that keratinocyte-derived IFN-λ plays a 
functional role in the patho physiology of 
cutaneous lupus erythematosus (CLE). This 
cytokine was expressed in the epidermis 
of CLE skin lesions and was detected at 
increased levels in CLE patient serum. 
IFN-λ was also expressed similarly to the chemokine CXCL9, which is a relevant ligand 
for the induction of systemic lupus erythematosus in mice. These results suggest that this 
cytokine supports lesional inflammation and drives inflammatory recruitment of immune 
cells in CLE. See page 133
Trans-splicing Treatment
Gene therapy to correct premature termination 
mutations in the type VII collagen gene is criti-
cal for treatment of severe forms of dystrophic 
epidermolysis bullosa (DEB); however, com-
monly used retroviral vector delivery systems 
are limited because of the 118-exon COL7A1 
mRNA. Thus, Murauer and colleagues dem-
onstrated that 3′ trans-splicing, involving a 
gene repair mechanism in which the cell spli-
ceosome recombines the endogenous target 
pre-mRNA and an exogenously delivered RNA 
molecule to generate a new reprogrammed 
mRNA, results in full reversion of the recessive 
DEB (RDEB) phenotype in cell culture. This breakthrough lays a foundation for ex vivo 
gene therapy approaches to RDEB. See page 74
A Link between Metastasis and Angiogenesis
Because lymphatic invasion is linked 
to metastasis in many cancers, Moussai 
and colleagues explored this relationship 
in cutaneous squamous cell carcinoma 
(SCC). Indeed, increased lymphatic vessel 
density and upregulated lymphangiogen-
esis genes were associated with SCC. In 
addition, vascular endothelial growth 
factor-C (VEGF-C), a critical lymphangio-
genesis mediator, was upregulated in 
inflammatory cells surrounding SCC, and peritumoral macrophages were identified 
surrounding SCC, suggesting that these cells may be a source of VEGF-C in the tumor 
microenvironment. These new insights into the mechanism of lymphangiogenesis 
adjacent to SCC may offer avenues for the development of therapeutics for aggressive 
or inoperable tumors. See page 229
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